Speaker
Ph.D., Mission BioCapital
Doug Crawford, Ph.D. at Mission BioCapital, spoke at 20th Annual Pain Therapeutics Summit (Burlingame, United States of America, 28–29 Sept 2026) in the session “The State of Pain Therapeutics Investing: What's Changed and Where Capital is Flowing in 2026”.
28–29 Sept 2026Burlingame, United States of America
MD, PPD, part of Thermo Fisher
MD, Albany Medical College
Ph.D., National Institute of Neurological Disorders & Stroke, National Institutes of Health
Ph.D., University of California San Francisco
MD, Cenexel
DDS, The Facial Pain Research Association
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Doug Crawford, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].